Jonathan Slonin, Chief Medical Officer at Pacira BioSciences, Inc. (PCRX), sold 7,920 shares at $24.09 ($191K) on 2025-11-17, disclosed to the SEC on 2025-11-19.
Scheduled sale ($191k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.09 | 3,960 | $95K | 50.0% |
| 2 | $24.09 | 3,960 | $95K | 50.0% |
| Total | $24.09 avg | 7,920 | $191K | 100% |
| Filing → |
| PCRX | SELL | 2025-01-06 | $16K | — | Filing → |
| PCRX | SELL | 2024-08-02 | $19K | — | Filing → |
| PCRX | SELL | 2024-07-03 | $80K | — | Filing → |